Shih W J, Wang A M, Domstad P A, Cho S R, DeLand F H
Eur J Nucl Med. 1985;11(1):43-5. doi: 10.1007/BF00440960.
Meningioma is one of the neoplasms in which there may be extraosseous localization of bone-seeking radiopharmaceuticals. Tumor calcification, calvarial erosion, and the formation of reactive bone have been proposed as the cause of this abnormal tracer localization. We present a patient with a frontal meningioma that was evaluated using 99mTc-methylene-diphosphonate bone scintigraphy, head computed tomography, and skull radiography; the homogeneous density seen in the radiographic studies corresponded to the area of bone-seeking-agent localization shown in the scintigram. At autopsy, bony tissue and a few psammoma bodies were found in the meningioma, and apparently accounted for the bone-tracer localization. There was no calvarial erosion and no formation of reactive bone. If skull-radiographic studies show a homogeneous, radio-opaque lesion with no reactive changes in the adjacent skull, a meningioma showing a localization of a bone-seeking radiopharmaceutical may be predicted to have bone-tissue formation with or without psammoma bodies.
脑膜瘤是一种可能存在亲骨性放射性药物骨外定位的肿瘤。肿瘤钙化、颅骨侵蚀和反应性骨形成被认为是这种异常示踪剂定位的原因。我们报告一名患有额叶脑膜瘤的患者,该患者接受了99mTc-亚甲基二膦酸盐骨闪烁显像、头部计算机断层扫描和颅骨X线摄影检查;X线摄影研究中所见的均匀密度与闪烁显像中显示的亲骨剂定位区域相对应。尸检时,在脑膜瘤中发现了骨组织和一些砂粒体,显然这是骨示踪剂定位的原因。没有颅骨侵蚀,也没有反应性骨形成。如果颅骨X线摄影研究显示一个均匀的、不透射线的病变,且相邻颅骨无反应性改变,那么可以预测显示亲骨性放射性药物定位的脑膜瘤可能有骨组织形成,伴有或不伴有砂粒体。